A Molecular Switch for Pancreatic Cancer Treatment Resistance Uncovered by Duke-NUS Researchers
Researchers at Duke-NUS Medical School have identified a crucial molecular "switch" that dictates whether pancreatic...
Knowledge and News for the Global Fight Against Cancer.
Researchers at Duke-NUS Medical School have identified a crucial molecular "switch" that dictates whether pancreatic...
In a landmark study that could redefine the future of preventive medicine, researchers at Stanford...
Researchers from the Salk Institute for Biological Studies, UNC Lineberger Comprehensive Cancer Center, and UC...
Dr. Vinay Prasad, a figure known for his outspoken critical analyses within the medical community...
WASHINGTON – Vinay Prasad, a prominent official at the Food and Drug Administration (FDA) whose...
Alnylam Pharmaceuticals, a leader in RNA interference (RNAi) therapeutics, has entered into a significant discovery...
The landscape of oncological care within the Department of Veterans Affairs (VA) is undergoing a...
Colorectal cancer, a formidable disease affecting the colon or rectum, is a growing public health...
The Pancreatic Cancer Action Network (PanCAN) has reaffirmed its dedication to advancing critical research and...
For decades, the scientific community has grappled with a perplexing paradox in colorectal cancer (CRC)...